Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 07-2024 | 04-2024 | 01-2024 | 10-2023 | 07-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,932 | -3,683 | -5,375 | 5,959 | -20,302 |
| Depreciation Amortization | 84 | 12 | 8 | 4 | 15 |
| Accounts receivable | -733 | 4 | -11 | -3 | 5 |
| Accounts payable and accrued liabilities | 6,047 | 5,299 | 2,588 | -690 | 661 |
| Other Working Capital | 7,053 | 5,759 | 2,023 | 180 | -3,532 |
| Other Operating Activity | -31,646 | -27,481 | -14,239 | -13,056 | -592 |
| Operating Cash Flow | $-24,126 | $-20,090 | $-15,007 | $-7,605 | $-23,745 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -457 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -225 | -225 | N/A | N/A | N/A |
| Investing Cash Flow | $-682 | $-225 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,419 | N/A | N/A | N/A | 4,002 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -47 |
| Financing Cash Flow | $4,419 | $N/A | $N/A | $N/A | $3,954 |
| Beginning Cash Position | 21,251 | 21,251 | 21,251 | 21,251 | 41,042 |
| End Cash Position | 862 | 936 | 6,245 | 13,646 | 21,251 |
| Net Cash Flow | $-20,389 | $-20,315 | $-15,007 | $-7,605 | $-19,791 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,126 | -20,090 | -15,007 | -7,605 | -23,745 |
| Capital Expenditure | -457 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -24,583 | -20,090 | -15,007 | -7,605 | -23,745 |